Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model
Publication year
2020Source
Oncoimmunology, 9, 1, (2020), article 1817653ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Radiation Oncology
Tumorimmunology
Journal title
Oncoimmunology
Volume
vol. 9
Issue
iss. 1
Subject
Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [246764]
- Electronic publications [134215]
- Faculty of Medical Sciences [93461]
- Open Access publications [107738]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.